Clinical Trial

Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

Completed
View on ClinicalTrials.gov →
Summary
This study aims to retrospectively evaluate patients who underwent surgical treatment for elastofibroma dorsi, a rare benign tumor typically located in the subscapular region of the chest wall. The study will analyze demographic and clinical features, risk factors, diagnostic imaging methods, postoperative complications, and recurrence rates. By identifying potential predictors of complications and recurrence, the study hopes to contribute to the understanding and management of this silent and often incidental lesion.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-25
notable Enrollment reduced: 130 -> 102 participants 2026-07-25
Trial Details
NCT Number NCT07010224
Lead Sponsor Ondokuz Mayıs University
Conditions Elastofibroma Dorsi
Enrollment 102 participants
Start Date 2010-01-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-24